Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
World Journal of Stem Cells|November 27, 2014
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapyJustin D Glenn, Katharine A Whartenby
Neurologic Clinics|November 22, 2017
The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to DiseaseEllen M Mowry, Justin D Glenn
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 5, 2016
Emerging Concepts on the Gut Microbiome and Multiple SclerosisJustin D Glenn, Ellen M Mowry
Journal of Neuroimmunology|December 25, 2017
Gemcitabine directly inhibits effector CD4 T cell activation and prevents experimental autoimmune encephalomyelitisJustin D Glenn, Patrick Xue, Katharine A Whartenby
Journal of Leukocyte Biology|February 15, 2019
Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lungJustin D Glenn, Charles Liu, Katharine A Whartenby
The Journal of Experimental Biology|February 2, 2010
Structural mechanics of the mosquito heart and its function in bidirectional hemolymph transportJustin D Glenn, Jonas G King, Julián F Hillyer
Journal of Neuroimmunology|November 29, 2019
MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitisJustin D Glenn, Itzy Morales Pantoja, Patrizio Caturegli, et al.
Stem Cells (Dayton, Ohio)|June 10, 2014
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitisJustin D Glenn, Matthew D Smith, Peter A Calabresi, et al.
The Journal of Biological Chemistry|July 13, 2013
KLF4 modulates expression of IL-6 in dendritic cells via both promoter activation and epigenetic modificationJason M Rosenzweig, Justin D Glenn, Peter A Calabresi, et al.
Pageof 2